indications for glp-1 agonists The science on receptor has outpaced the public narrative. While headlines chase the latest prescription numbers, evidence-based practice demands we hold the line: obesity is a chronic, relapsing condition; not Benefits and Risks of GLP-1

Providers will need to balance appropriate prescribing with growing consumer interest

Removing A amyloid plaques is a therapeutic target for Alzheimers disease, as seen in recent market entries like Amgens leqembi and the upcoming approval for donanemab

Exendin-4 improves glycemic control, ameliorates brain and pancreatic pathologies, and extends survival in a mouse model of Huntington's disease

Menopause also accelerates the natural loss of muscle mass, a condition known as sarcopenia, and reduces your total daily energy expenditure, making it even harder to maintain a healthy weight or lose excess fat

2024;105:S117314

For example, females had a higher risk of anxiety (2.19, 95% CI: 2.142.24) and suicidal ideations or attempts (2.53, 95% CI: 2.322.76) compared to males